Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M443Revenue $M3,799Net Margin (%)--Altman Z-Score--
Enterprise Value $M438EPS $-2.4Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book36.210-y EBITDA Growth Rate %--Quick Ratio1.7Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-135.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M23.6ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with LIFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LIFEMario Gabelli 2014-03-31 Sold Out -0.47%$75.75 - $76.07
($75.91)
$ 18.75-75%Sold Out0
LIFEJohn Paulson 2014-03-31 Sold Out -0.03%$75.75 - $76.07
($75.91)
$ 18.75-75%Sold Out0
LIFEJoel Greenblatt 2014-03-31 Sold Out -0.03%$75.75 - $76.07
($75.91)
$ 18.75-75%Sold Out0
LIFEFirst Eagle Investment 2014-03-31 Sold Out -0.02%$75.75 - $76.07
($75.91)
$ 18.75-75%Sold Out0
LIFEJohn Paulson 2013-12-31 Reduce-0.04%$74.72 - $75.78
($75.43)
$ 18.75-75%Reduce 50.48%89,657
LIFEFirst Eagle Investment 2013-12-31 Reduce-0.03%$74.72 - $75.78
($75.43)
$ 18.75-75%Reduce 63.70%72,600
LIFEJoel Greenblatt 2013-12-31 Add0.02%$74.72 - $75.78
($75.43)
$ 18.75-75%Add 320.36%14,885
LIFEJohn Paulson 2013-09-30 Reduce-0.58%$74.06 - $74.96
($74.61)
$ 18.75-75%Reduce 85.90%181,053
LIFEFirst Eagle Investment 2013-09-30 Reduce-0.06%$74.06 - $74.96
($74.61)
$ 18.75-75%Reduce 56.11%200,000
LIFEJoel Greenblatt 2013-09-30 Reduce-0.02%$74.06 - $74.96
($74.61)
$ 18.75-75%Reduce 67.32%3,541
LIFEJohn Paulson 2013-06-30 Reduce-4.93%$64.57 - $74.41
($72.6)
$ 18.75-74%Reduce 91.31%1,284,433
LIFEJohn Rogers 2013-06-30 Sold Out -1.9%$64.57 - $74.41
($72.6)
$ 18.75-74%Sold Out0
LIFERobert Olstein 2013-06-30 Sold Out -1.1%$64.57 - $74.41
($72.6)
$ 18.75-74%Sold Out0
LIFEMeridian Funds 2013-06-30 Sold Out -0.83%$64.57 - $74.41
($72.6)
$ 18.75-74%Sold Out0
LIFERonald Muhlenkamp 2013-06-30 Sold Out -0.67%$64.57 - $74.41
($72.6)
$ 18.75-74%Sold Out0
LIFEMario Gabelli 2013-06-30 Add0.59%$64.57 - $74.41
($72.6)
$ 18.75-74%Add 3187.35%1,311,520
LIFEFirst Eagle Investment 2013-06-30 Buy 0.1%$64.57 - $74.41
($72.6)
$ 18.75-74%New holding455,735
LIFEJoel Greenblatt 2013-06-30 Reduce-0.02%$64.57 - $74.41
($72.6)
$ 18.75-74%Reduce 33.08%10,836
LIFERonald Muhlenkamp 2013-03-31 Reduce-1.77%$49.03 - $65.27
($60.09)
$ 18.75-69%Reduce 76.85%50,000
LIFERobert Olstein 2013-03-31 Reduce-0.62%$49.03 - $65.27
($60.09)
$ 18.75-69%Reduce 38.51%99,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LIFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LIFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Flynn James E 2015-05-12Buy50,000$1433.93view
AKKARAJU SRINIVASFormer 10% Owner 2015-05-12Buy320,000$1433.93view
Sofinnova Venture Partners IX,10% Owner 2015-05-12Buy320,000$1433.93view
UPRICHARD DAVID CDirector 2013-05-29Sell2,010$74.04-74.68view
COTTINGHAM JOHN AChief Legal Officer 2013-05-28Sell60,000$74.03-74.67view
LORIMIER BRADLEY GDirector 2012-12-11Sell20,000$51.06-63.28view
GRIMM DONALD WDirector 2012-11-20Sell12,052$47.94-60.89view
RICHARD KELLIChief Accounting Officer 2012-11-06Sell6,194$49.19-61.88view
LEVINE ARNOLD JDirector 2012-10-15Sell6,958$48.52-61.36view
LUCIER GREGORY TCEO 2012-09-18Sell169,868$50-62.5view

Quarterly/Annual Reports about LIFE:

News about LIFE:

Articles On GuruFocus.com
No related article found.

More From Other Websites
aTyr Pharma Announces Transitions In Clinical Development & Operations Jul 20 2015
A Chinese Financial Implosion Might Spur Opportunities - Here Are 4 Stocks to Watch Jul 14 2015
aTyr Pharma Added To Russell 2000®, 3000® And Global Indexes Jun 29 2015
aTyr Pharma Announces First Quarter 2015 Operating Results Jun 18 2015
Traders search for key to Lifelock Jun 08 2015
aTyr Pharma to Present at 35th Annual William Blair Growth Stock Conference Jun 03 2015
Coverage initiated on aTyr Pharma by JP Morgan and Citigroup Jun 01 2015
aTyr Pharma, Inc. Announces Closing of Initial Public Offering May 12 2015
aTyr Pharma Appoints Rare Disease Pioneer Mark Goldberg, M.D., to Board of Directors May 11 2015
aTyr Pharma, Inc. Announces Pricing of Initial Public Offering May 11 2015
aTyr Pharma Receives U.S. FDA Orphan Designation for ResolarisTM May 11 2015
Pisani: Markets shrug at big week of biotech IPOs May 07 2015
aTyr Pharma, Inc. Announces Pricing of Initial Public Offering May 06 2015
IPO Outlook: Down-Home Cookin', Fast-Casual Bojangles' Sizzles Investors May 05 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK